Document is current
Any future updates will be listed below
-
Authors
Yousef, Mahmoud
Yousef, Abdelrahman
Hurd, Mark W.
Pillai, Ashwathy
Chowdhury, Saikat
Snyder, Rebecca
Knafl, Mark
Lewis, Ryan L.
Roy, Paul M.
Fanaeian, Mohammad
Albarouki, Sali
Castelnovo, Luca F.
Peterson, Jennifer
Smaglo, Brandon G.
Wolff, Robert A.
Pant, Shubham
Willis, Jason
Huey, Ryan
Overman, Michael
Tzeng, Ching-Wei
Kim, Michael P.
Ikoma, Naruhiko
Maxwell, Jess E.
Katz, Matthew H. G.
Wang, Huamin
Maitra, Anirban
Koay, Eugene
Ludmir, Ethan B.
Chen, Anthony
Lopez, Camila
Ying, Haoqiang
Shen, John Paul
Zhao, Dan
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR180035 & RP240392 to J.P.S.,)
Cancer Center Support Grant (P30 CA016672)
National Cancer Institute (K22 CA234406 to J.P.S.,)
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 2 April 2025
First Online: 17 April 2025
Declarations
:
: This study was approved by the MD Anderson Institutional Review Board (IRB), protocol number 2023-0091. A waiver of informed consent was granted per the USA federal regulation 45 CFR 46.116(f) for this retrospective study.
: Brandon Smaglo: Consulting for Ipsen.Shubham Pant: Advisory for Zymeworks, Ipsen, Novartis, Janssen, Boehringer Ingelheim, and AskGene Pharma; and he receives research funding from Mirati Therapeutics, Lilly, Xencor, Novartis, Rgenix, Bristol-Myers Squibb, Astellas Pharma, Framewave, 4D Phar-ma, Boehringer Ingelheim, NGM Biopharmaceuticals, Janssen, Arcus Biosciences, Elicio Therapeutics, Bionte, Ipsen, Zymeworks, Pfizer, ImmunoMET, Imuneering, and Amal Therapeutics. Anirban Maitra: Consultant for Tezcat Biosciences is listed as an inventor of a patent licensed to Thrive Earlier Detection (an Exact Sciences Company) relevant to early detection of pancreatic cancer. John Paul Shen: Grant/research support/collaboration: Celsius Therapeutics, BostonGene, Caris Life Sciences, Natera, Xilis, Palantir, Genentech. Consulting/stock ownership: Engine Biosciences, NaDeNo Nanoscience.Dan Zhao: Clinical trials with hMirati/BMS, Phanes, CARsgen, TriSalus and Affini-T; Consulting for Ipsen.
